PCV131 A Retrospective Study Comparing Compliance, Persistence, and Blood Pressure Control Between Free-Drug and Single-Pill Combination Therapies in Korean Hypertensive Patients  by Hong, J.M. et al.
A534  VA L U E  I N  H E A LT H  1 6  ( 2 0 1 3 )  A 3 2 3 – A 6 3 6  
days post-stroke) and early patients. Models accounting for patient health utility 
were significantly different (p< 0.05). ConClusions: These findings complement 
the more descriptive summaries of a comprehensive matrix of sources of support 
within regions and localities (Department of Health, 2007), with which people living 
with stroke may interact. Exploring what patients and carers consider important 
in the provision of stroke support services, will ensure that service re-design is 
user-focused to maximum utility.
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Coronary syndrome: a disCrete-ChoiCe exPeriment and anaLytiC 
hierarChy ProCess
Mühlbacher A.C., Bethge S., Kaczynski A., Juhnke C.
Hochschule Neubrandenburg, Neubrandenburg, Germany
objeCtives: Diseases of the cardiovascular system are the main causes of death in 
Germany and other industrial countries. Different therapeutic approaches exist as 
well as several treatment options. How people who have suffered from an acute cor-
onary syndrome, value aspects of their medical treatment is not very well analyzed 
until today. The objective of this empirical investigation was to evaluate patient’s 
preferences regarding different antiplatelet medication options following an acute 
coronary syndrome. Methods: Primary method was a Discrete-Choice-Experiment 
that included 6 patient-relevant attributes. Furthermore an Analytic-Hierarchy 
Process (AHP) was used to test the applicability of the method and to compare the 
results. The Discrete-Choice-Experiment (DCE) was conducted using a fractional 
factorial NGene-design with priors and the statistical data analysis used a random 
effect logit model. AHP was conducted using the eigenvalue method. Results: The 
preference analysis of N= 683 patients showed a clear dominance for the attribute 
“reduction of the risk of death” (DCE coef.: 0.803; AHP coef.: 0.402.). Rank 2 in AHP 
the “reduction of heart attack risk” (DCE coef: 0.464; AHP coef.: 0.272.) and in the 
DCE was “shortness of breath” (DCE coef.: 0.550; AHP coef.: 0.165.). The side effect 
of “bleeding” (DCE coef.: 0.400; AHP coef.: 0.117.) joined accordingly. The “frequency 
of administration” was less important in DCE and AHP (DCE coef: 0.025; AHP coef. 
0,044.). ConClusions: The results of both methods generated an almost equal 
ranking of the included features. The highest value for patients within a treatment 
decision was the mortality reduction. The consideration of patient preferences in 
therapeutic decisions implies stronger patient focus and can at the same time be 
used for the development of effective therapies after acute coronary syndrome. 
The preference data generated can be used for health care decision makers and 
stakeholders to represent the patient’s benefit at the same time.
PCV130
ComParing the PerformanCe of the eQ-5d-5L with the eQ-5d-3L in 
stroke Patients in JaPan
Noto S.1, Izumi R.1, Moriwaki K.1, Igarashi A.2, Ikeda S.3, Fukuda T.4, Shiroiwa T.4,  
Kobayashi M.5, Saito S.6, Shimozuma K.7
1Niigata University of Health and Welfare, Niigata, Japan, 2Tokyo Univ. Faculty of Pharmacy, 
Tokyo, Japan, 3International University of Health and Welfare, Otawara City, Tochigi, Japan, 
4National Institute of Public Health, Saitama, Japan, 5CRECON Research & Consulting Inc, Tokyo, 
Japan, 6Okayama University, Okayama, Japan, 7Ritsumeikan University, Kusatsu, Japan
objeCtives: To assess the performance of the EQ-5D-5L Japanese version com-
pared with the EQ-5D-3L in clinical setting targeted at patients with stroke in 
Japan. Methods: The stroke patients were recruited from six rehabilitation hos-
pitals in Japan. The proxy of the patients completed a questionnaire including the 
two versions of the EQ-5D. We tested the inconsistency, the redistribution proper-
ties, and the ceiling effect. Results: A total 533 patients were recruited: 61% male, 
15-99 (mean= 67) years old. Diagnoses of patients were infarction (54.6%), hemor-
rhage (35.5%), and other (9.9%). The proportion of inconsistent responses (i.e., 3L 
responses that were at least two levels away from the 5L responses) was 3.6%. In 
particular the proportion in MOBILTY was 14.6%. Regarding redistribution, 52-61% 
of the patients answering level 2 with the 3L version redistributed their responses 
to levels 2 or 4 with the 5L version. A relative 3% reduction of the ceiling effect was 
found. ConClusions: Our findings suggest that the EQ-5D-5L Japanese version 
performs better in at least some properties analyzed. Further study is necessary to 
clarify other psychometric properties.
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objeCtives: Existing evidences indicate that single-pill antihypertensive combina-
tions (SPC) have greater rates of adherence and more effective lowering of blood 
pressure than free-drug combinations (FC). SPC therapy has been used in Korea for 
the purpose of achieving optimal blood pressure control. However it is questioned 
whether such existing positive evidence toward SPC from western countries can 
be found in the Korean population. Methods: This study compared compliance, 
persistence and blood pressure change of SPC versus FC using the medical charts of 
1,940 patients from 17 Korean general hospitals (GH1-17). The hypertensive patients 
with SPC or FC prescription, more than 40 years old, no history of hospitalization, 
visited GH1-17 from January 1, 2010 to December 31, 2011 were included. Compliance 
was compared using the Medication Progression Ratio (MPR), calculated as the ratio 
between the days medication was taken and days in a time interval. Persistence was 
measured as the number of days from the index date to the therapy discontinuation 
date. The blood pressure (BP) change was calculated as the difference between the first 
and the last visit. Results: Overall compliance measured by MPR was 0.71 for the 
SPC group and 0.69 for the FC group, with the difference being statistically significant. 
an extremely low quality of life. These findings should be considered in future 
planning of interventions in stroke patients.
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objeCtives: To determine the feasibility of using the Experience Sampling Method 
(ESM) to obtain accounts of the momentary experience of Health Related Quality 
of Life (HRQOL) and compare these to retrospective global measures of HRQOL and 
utilities derived from choice under uncertainty. Methods: An experience-sampling 
study of 139 participants from three different patient groups and a control sample 
examined the momentary experience of HRQOL (mom-HRQOL). Global retrospec-
tive HRQOL measures were also administered. Feasibility of was determined by 
assessing willingness to participate in the study and by analysing the percentage 
of drop-outs and the number of completed beep questionnaires. Bivariate correla-
tions between mom-HRQOL and momentary positive affect (PA), negative affect (NA) 
and physical symptoms (PS) for each participant were determined. Furthermore, 
correlations between mom-HRQOL, PA, NA and PS on the one hand and retrospec-
tive global health (EQ-VAS), the EQ-5D utility, the SF-6D utility and the TTO on the 
other hand were determined. Results: The overall participation rate was low but 
there were no drop-outs and the number of completed beeps was comparable to 
other studies. For most participants, the correlation between mom-HRQOL and 
momentary PA, NA and PS was in the expected direction. Correlations between 
ESM data on HRQOL, PA, NA and PS and retrospective measures were moderate to 
high, with the exception of the TTO. ConClusions: Overall, this study extends our 
knowledge of the similarities and differences between ESM data on HRQOL, feelings 
and symptoms and retrospective measures of HRQOL, which may aid future health 
care research and decision making.
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objeCtives: EUprimecare is a European Union project aimed at analyzing the costs 
and quality of the different models of primary care (PC) in Europe. The aim of this 
paper is to analyze the management of patients with hypertension in PC services 
in Spain compared to other European countries, the satisfaction of these patients 
with PC services and their self-perceived health status. Methods: Cross-sectional 
study. We conducted a population survey by telephone among PC users in each of 
the consortium countries (Germany, Spain, Estonia, Finland, Hungary, Italy and 
Lithuania). The questionnaire included information on sociodemographic charac-
teristics, health status, satisfaction, utilization of PC services, and frequency of 
some interventions carried out by PC professionals. The survey was conducted to 
431-432 PC users in each country (Ntotal = 3020). We use satisfaction, health status 
and sociodemographic variables to consider the situation of patients with hyperten-
sion in PC. Results: The percentage of users of primary care services who reported 
having hypertension in Spain was 21.6% (N = 93), lower than the overall average 
(34.9%). 97% of patients resident in Spain were diagnosed by their primary care 
physicians versus 82.6% of the European average. The 91.4% of patients in Spain 
claimed to be in treatment to hypertension (EU average= 92.3%) and in 92.9% of 
cases the treatment was prescribed by their PC doctors (EU average= 84.5%). Only 
7.5% of patients claimed that their health was poor or very poor, the lowest propor-
tion of all countries evaluated. ConClusions: The patient with hypertension in 
Spain is diagnosed and managed by PC professionals more frequently than in other 
European countries. The self-perception of these patients in Spain is good and they 
were satisfied with the services of AP. The overall satisfaction of the patients with 
AP services was high but not significantly different from other countries.
PCV128
user PreferenCes for stroke serViCes in waLes
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Bangor University, Bangor, UK
objeCtives: To investigate patient and family carer preferences for stroke support 
services. Methods: Discrete choice experiment (DCE) using a fractional factorial 
design, folded into nine binary choices, containing four attributes: format of service 
(group, individual); service provider (hospital stroke team, primary care, voluntary 
sector); provision of additional social and leisure activities (provided, not provided); 
and time to plan and make the journey (1,2,4 hours). Attributes and levels were 
defined by a review of policy documentation and two workshops with patients and 
family carers (n= 8). Patients (six months post-stroke) and their family carers were 
recruited from four stroke-services in Wales, to complete a paper questionnaire 
including the DCE and validated instruments to facilitate pre-specified sub-group 
analyses. Data were analysed in STATA using a random effects logit model. Marginal 
rate of substitution (MRS) used journey time as the value attribute. Results: A total 
of 144/474 (30%) eligible patients requested the questionnaire, 80 (56%) completed 
(mean age 70.8 years (sd 11.1). A total of 34/74 family carers who requested the 
questionnaire completed. All four attributes were significant for patients (p< 0.05), 
only format of service and journey for carers. Patients preferred support services on 
an individual basis (p= 0.00, MRS= 128.61 minutes), with additional social and leisure 
activities (p= 0.00, MRS= 64.07 minutes). Family carers were willing to trade more 
journey time for services provided on an individual basis (p= 0.00, MRS= 273.73 min-
utes). Sub-group analysis showed significant differences between established (> 315 
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objeCtives: There are few studies in Spain about outcomes at six months in 
terms of health-related quality of life (HRQoL) in patients hospitalized by heart 
failure (HF). The objective of the study was to evaluate changes in HRQoL from 
baseline to six months post discharge in patients with HF through three ques-
tionnaires, SF-12, EQ-5D-3L and Minnesota Living with Heart Failure questionnaire 
(MLHFQ). Methods: This is a prospective study with 976 patients admitted by HF. 
Patients completed questionnaires during their hospitalization and at six months. 
The MLHFQ is a specific instrument which has 21 items with an overall scale, physi-
cal (8 items) and emotional (5 items) subscales. MLHFQ items are scoring from 0 
(best) to 5 (worse). Total score ranges from 0 to 105, physical domain from 0 to 40 
and emotional from 0 to 25. SF-12 has two dimensions, Physical Summary Score 
(PCS) and Mental Summary Score (MSC) which scores range from 0 (worst) to 100 
(best). EQ-5D has been measured according to the Spanish tariffs by time trade-off 
and the visual analogic scale. We used general linear model to study gains in each 
dimension adjusted by baseline score, age, gender and readmissions in the previous 
6 months. Results: Mean age was 76.0 (SD= 10.4), there were a 53.3% of men and 
33.1% of readmissions in the previous six months. Regarding all questionnaires and 
dimensions, baseline status influence in gains, the worse the baseline the more 
the gains. Likewise men have greater gains and patients readmitted lower in all 
domains. Age has an influence in all domains but emotional dimension of MLHFQ 
and MSC of SF-12. ConClusions: Adjusted by baseline score and readmissions, 
men have greater improvements in all domains of MLHFQ, SF-12 and EQ-5D. On the 
other hand, the younger the patients the higher the improvement is, however age 
does not have any influence in psychological domains.
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objeCtives: Warfarin anticoagulation is monitored using international normal-
ized ratio (INR); specified with the narrow/wide 2.0–3.0/1.9–3.5 therapeutic target 
range, and converted to time in the therapeutic range (TTR, total percentage of 
time the INR reading is within the INR therapeutic range). We explored the impact 
of I) INR monitoring and II) TTR on patients’ quality of life (QoL). Methods: A 
total of 647 unselected patients visiting 3 health centres in Pirkanmaa district 
(31.01–11.02.2011), Finland participated to prospective study. To assess INR moni-
toring or TTR and QoL, Beta regressions were applied in Stata and EQ-5D-3L-based 
QoL (Smithson&Verkuilen transformation) 3 months after the baseline visit was 
the dependent variable. The covariates were CHADS2(congestive heart failure, 
hypertension, age> 75, diabetes mellitus, stroke) score, other comorbidities, 
baseline QoL, time difference (days) between dependent variable measurement 
and mean TTR time point (subgroup model), and INR monitoring (yes/no in total 
population) or TTR % (subgroup model). Results: A total of 28 patients (46.43% 
male; means: age 73.21 years, CHADS2-score 2.39, other comorbidities amount 
1.71, baseline QoL 0.8334, INR tests 4.21, 66.31%/82.86% INR measurements on 
the narrow/wide range) had INR measurements (“warfarinization group”) during 
the 3 months follow-up. 27 patients had calculable TTR (Rosendaal method) that 
was 69.29%/86.66% on the narrow/wide range. In the beta regression (N 393, +1 
marginal change), CHADS2-score (-0.021), other comorbidities amount (-0.030), 
baseline QoL (+0.350), and INR monitoring (p= 0.299, -0.042, SE 0.044) predicted QoL. 
The mean adjusted QoL with/without INR monitoring in the warfarinization-like 
group was 0.794/0.836. In subgroup Beta regression including only warfariniza-
tion patients, higher TTR levels predicted lower QoL (p< 0.050, +1 %-unit marginal 
change -0.006 [SE 0.007]; discrete change -0.284 in the wide range from 35.3% to 
100.0%). ConClusions: INR monitoring may predict QoL loss and, surprisingly, 
higher TTR predicts lower QoL. Larger studies are needed to confirm the potential 
relationship between TTR and QoL.
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objeCtives: Assess health-related quality of life (HRQoL) of patients with 
CAD. Methods: The main observational study cohort enrolled consecutive patients 
admitted in ICU at tertiary care hospital and diagnosed with CAD. Demographic 
information, risk factors for CAD, and angiographic findings were collected. EQ-5D 
was administered at 1-year follow-up. EQ-5D levels were dichotomized: ‘no prob-
lems’ (level 1), ‘any problem’ (levels 2 and 3). Linear stepwise regression was used 
to assess predictors of all 5 health states (mobility, self-care, usual activities, pain/
discomfort, anxiety/depression). The independent variables studied include age, 
hypertension, diabetes, CHF, gender, prior MI, final diagnosis, MI type, and final 
treatment. Respondents reporting problems EQ-5D dimensions were stratified by 
presence of diabetes and compared. Results: Of 960 CAD patients enrolled for the 
main cohort study (30% diabetic), 306 (male, 230; diabetics, 64) responded HRQoL 
questionnaire at 1-year. On liner regression, presence of diabetes was independent 
predictor of 4/5 EQ-5D HRQoL dimensions: mobility (p= 0.019), problems performing 
usual activities (p= 0.041), pain/discomfort (p< 0.001); anxiety/depression (p= 0.001). 
At 1-year, mean EQ-5D utility index score and VAS score were significantly lower 
for diabetes vs non-diabetics (0.76±0.13 vs. 0.83±0.15, p= 0.0003 and 67.8 ± 8.8 vs. 
73.6±5.4, p= 0.0001, respectively) with more problems with performing usual activi-
ties (56.3% vs. 41.3%, p= 0.04), pain or discomfort (51.6% vs. 17.8%, p= 0.0001) as 
well as anxiety/depression (32.8% vs 14.9%, p= 0.002). ConClusions: Among CAD 
This was especially evident for SPC patients in the 40~64 year age group (0.71 for SPC, 
0.69 for FC) and patients with two or more comorbidities (0.73 for SPC, 0.69 for FC) (P= 
0.0011). However, no statistical significance was observed for the difference both in 
persistence and the BP change between the two groups. ConClusions: Our study 
suggests that compliance tends to be improved by the use of SPC compared with 
FC. Unlike the previous western studies, it was hard to find a significant increase in 
persistence or BP change with SPC therapy in this study.
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heaLth reLated QuaLity of Life and deViCe-aCCePtanCe in Patients 
with imPLantaBLe CardioVerter-defiBriLLators and teLemonitoring
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objeCtives: Telemedical systems (TMS) and data management for implantable 
cardioverter-defibrillators (ICD) promise to reduce costs and optimize patient 
care. Depressive symptoms are common among patients with an ICD and the 
health related quality of life (HRQoL) is affected by the underlying disease and the 
implanted device, respectively. TMS might improve the HRQoL of patients and ICDs 
acceptance due to closer monitoring and, thereby, an increased level of perceived 
safety. In this RCT, changes in the level of depression, HRQoL and ICD-acceptance 
over a period of six months after ICD-implantation were investigated. Methods: 
A total of 161 patients (80.7% male; age: 64,1±14,6; 82% with coronary disease, 11% 
with DCM) with an ICD were randomized at the day of implantation into interven-
tion (n= 82) or control group (n= 79). The intervention group was equipped with a 
telemonitoring-system that transferred ICD-data from the patients’ home to the 
medical practitioner. The control group received regular care. Patients were asked to 
fill out three questionnaires (the generic EQ-5D, the depression specific HADS and 
the device specific FPAS); the follow-up period was six month, with postal surveys 
on a monthly basis. Results: Nine patients dropped out before survey comple-
tion. A total of 140 patients filled out at least two sets of questionnaires and were 
included in the analyses. After six months the mean improvement in the HRQoL 
(EQ-5D-Index) in the telemonitoring group was 10.7 points compared to baseline 
(p= .006) while the mean change in HRQoL in the control group was 5.5 (p= .138). FPAS 
and HADS-D showed small but non-significant advantage for the telemonitoring 
group. ConClusions: Preliminary results suggest that TMS have the ability to 
improve HRQoL of patients with ICDs. Results on effects towards depression and 
anxiety and enhancement of ICDs acceptance are also promising. Since ICDs are 
used in chronic diseases a longer follow-up period seems to be required to validate 
the effects.
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objeCtives: To assess convergent and divergent validity of a new questionnaire 
(SAFUCA) developed to measure satisfaction with medical care in patients with 
non valvular atrial fibrillation. Methods: The 25-item reduced version instru-
ment was administered along with the Treatment Satisfaction Questionnaire for 
Medication (TSQM), and 5 Visual Analog Scales (VAS) measuring: Health Related 
Quality of Life (HRQoL), Effectiveness and Overall Satisfaction assessed by the 
patient; and Effectiveness and Tolerability assessed by the clinician. A convenience 
sample of 230 patients recruited at 7 health centers (5 hospitals and 2 primary care 
centers) in Spain was used. Second Order Exploratory Factor Analysis (SO-EFA) and 
correlation with VAS scales were computed. Results: SAFUCA dimensions cor-
related (p< 0.001) higher with corresponding TSQM dimensions (e.g.: Effectiveness 
r= 0.450, Convenience r= 0.457, Undesired Effects r= -0.340, Overall satisfaction 
r= 0.651), while SO-EFA made evident differences regarding the assessment of 
satisfaction with INR controls, interference in QoL and Medical Care. Correlation 
pattern between VAS scores was significantly different between primary care cent-
ers and hospitals, with a higher correlation between patient and clinician scores 
observed in primary care (e.g.: Effectiveness rPC= 0.430 vs. rH= 0.057). Similarly, 
correlation patterns between VAS concurrent scales and SAFUCA dimensions 
differed between center types. While high correlations between Effectiveness 
dimension and patient satisfaction VAS were observed in both cases (rPC= 0.521 
vs. rH= 0.516), correlation of Tolerability with Undesired Effects differed between 
centers (rPC= -0.474 vs. rH= -0.085). ConClusions: The 25-item questionnaire 
exhibits good convergent and divergent validity values. Differences between 
types of health care centers in correlation patterns were meaningful and worth 
of further research.
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